Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1991 1
1992 1
1994 1
1996 1
1997 1
1999 2
2000 3
2001 2
2002 3
2004 3
2005 3
2006 2
2007 2
2008 5
2009 6
2010 4
2011 7
2012 5
2013 6
2014 4
2015 14
2016 15
2017 9
2018 8
2019 9
2020 6
2021 6
2022 13
2023 10
2024 2
2025 3
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
What causes hidradenitis suppurativa ?-15 years after.
Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González-López MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GBE, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, MacLeod AS, Martorell A, Marzano AV, Matusiak Ł, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LAV, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH. Zouboulis CC, et al. Among authors: gulliver wpf. Exp Dermatol. 2020 Dec;29(12):1154-1170. doi: 10.1111/exd.14214. Exp Dermatol. 2020. PMID: 33058306 Free article. Review.
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Haberman RH, MacFarlane KA, Catron S, Samuels J, Blank RB, Toprover M, Uddin Z, Hu J, Castillo R, Gong C, Qian K, Piguet V, Tausk F, Yeung J, Neimann AL, Gulliver W, Thiele RG, Merola JF, Ogdie A, Rahman P, Chakravarty SD, Eder L, Ritchlin CT, Scher JU. Haberman RH, et al. Among authors: gulliver w. BMJ Open. 2022 Dec 23;12(12):e063650. doi: 10.1136/bmjopen-2022-063650. BMJ Open. 2022. PMID: 36564123 Free PMC article.
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delorme I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball AB, Kirby JS, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein LA, Piguet V, Sayed C, Tan J, Naik HB. Garg A, et al. Among authors: gulliver w. J Am Acad Dermatol. 2022 May;86(5):1092-1101. doi: 10.1016/j.jaad.2021.01.059. Epub 2021 Jan 23. J Am Acad Dermatol. 2022. PMID: 33493574 Free PMC article. Review.
Psoriasis comorbidities.
Guenther L, Gulliver W. Guenther L, et al. Among authors: gulliver w. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S77-87. doi: 10.2310/7750.2009.00024. J Cutan Med Surg. 2009. PMID: 19799830 Review.
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, Thomas LF, Traks T, Uebe S, Assmann G, Baudry D, Behrens F, Billi AC, Brown MA, Burkhardt H, Capon F, Chung R, Curtis CJ, Duckworth M, Ellinghaus E, FitzGerald O, Gerdes S, Griffiths CEM, Gulliver S, Helliwell PS, Ho P, Hoffmann P, Holmen OL, Huang ZM, Hveem K, Jadon D, Köhm M, Kraus C, Lamacchia C, Lee SH, Ma F, Mahil SK, McHugh N, McManus R, Modalsli EH, Nissen MJ, Nöthen M, Oji V, Oksenberg JR, Patrick MT, Perez White BE, Ramming A, Rech J, Rosen C, Sarkar MK, Schett G, Schmidt B, Tejasvi T, Traupe H, Voorhees JJ, Wacker EM, Warren RB, Wasikowski R, Weidinger S, Wen X, Zhang Z; BSTOP study group; Estonian Biobank research team; Barton A, Chandran V, Esko T, Foerster J, Franke A, Gladman DD, Gudjonsson JE, Gulliver W, Hüffmeier U, Kingo K, Kõks S, Liao W, Løset M, Mägi R, Nair RP, Rahman P, Reis A, Smith CH, Di Meglio P, Barker JN, Tsoi LC, Simpson MA, Elder JT. Dand N, et al. Among authors: gulliver w. Nat Commun. 2025 Feb 28;16(1):2051. doi: 10.1038/s41467-025-56719-8. Nat Commun. 2025. PMID: 40021644 Free PMC article.
Criteria for Hidradenitis Suppurativa Competence Centers.
Marzano AV, Bechara FG, Shi VY, Martorell A, Hsiao JL, Van der Zee HH, Villani AP, Alavi A, Ingram JR, Sayed CJ, Tzellos T, Chandran NS, Ju Q, Kurokawa I, Frew JW, Gulliver WPF, Rivitti-Machado MC, Wortsman X, McGrath BM, Pintori G, Jordan V, Thomas N, Alarcon I, Zouboulis CC. Marzano AV, et al. Among authors: gulliver wpf. Dermatol Ther (Heidelb). 2026 Jul;16(7):3445-3460. doi: 10.1007/s13555-026-01783-1. Epub 2026 May 23. Dermatol Ther (Heidelb). 2026. PMID: 42176118 Free PMC article.
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations.
Alhusayen R, Dienes S, Lam M, Alavi A, Alikhan A, Aleshin M, Bahashwan E, Daveluy S, Goldfarb N, Garg A, Gulliver W, Jaleel T, Kimball AB, Kirchhof MG, Kirby J, Lenczowski J, Lev-Tov H, Lowes MA, Lara-Corrales I, Micheletti R, Okun M, Orenstein L, Poelman S, Piguet V, Porter M, Resnik B, Sibbald C, Shi V, Sayed C, Wong SM, Zaenglein A, Veillette H, Hsiao JL, Naik HB. Alhusayen R, et al. Among authors: gulliver w. J Am Acad Dermatol. 2025 Apr;92(4):825-852. doi: 10.1016/j.jaad.2024.11.071. Epub 2024 Dec 24. J Am Acad Dermatol. 2025. PMID: 39725212 Free article.
Genetic liability to psoriasis predicts severe disease outcomes.
Saklatvala JR, Lessard S, Teder-Laving M, Thomas LF, Ramessur R, Zierer J, Åsvold BO, Barton A, Baudry D, Bowes J, Brumpton B, Bruno S, Chandran V, Chatelain C, de Rinaldis E, Elder JT, Ellinghaus D, Foerster J, Franke A, Gladman DD, Gulliver W, Hüffmeier U, Huilaja L, Hveem K, Khader S, Kingo K, Klinger K, Kolbinger F, Kõks S, Liao W, Nair RP, Nititham J, Rahman P, Reis A, Sagoo MK, Stuart PE, Tasanen K, Traks T, Tsoi LC, Uebe S, Watts K; BSTOP study group; Barker JN, Mahil SK, Langan SM; FinnGen; Estonian Biobank research team; Brown SJ, Løset M, Paternoster L, Dand N, Smith CH, Simpson MA. Saklatvala JR, et al. Among authors: gulliver w. Genome Med. 2025 Dec 17;18(1):14. doi: 10.1186/s13073-025-01561-2. Genome Med. 2025. PMID: 41408349 Free PMC article.
Treating to Target(s) With Interleukin-17 Inhibitors.
Lynde CW, Beecker J, Dutz J, Flanagan C, Guenther LC, Gulliver W, Papp K, Rahman P, Sholter D, Searles GE. Lynde CW, et al. Among authors: gulliver w. J Cutan Med Surg. 2019 Mar/Apr;23(2_suppl):3S-34S. doi: 10.1177/1203475418824565. Epub 2019 Feb 11. J Cutan Med Surg. 2019. PMID: 30742778 Review.
142 results